189 related articles for article (PubMed ID: 35527100)
1. Pregnancy Associated Breast Cancer Among Israeli BRCA1/BRCA2 Carriers in a High-Risk Clinic.
Faermann R; Friedman E; Kaidar-Person O; Brodsky M; Neiman OH; Shalmon A; Gotlieb M; Yagil Y; Samocha D; Feldman DM; Weidenfeld J; Sklair-Levy M
Acad Radiol; 2023 Feb; 30(2):248-254. PubMed ID: 35527100
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience.
Bufman H; Faermann R; Halshtok-Neiman O; Shalmon A; Gotlieb M; Samoocha D; Yagil Y; Feldman DM; Friedman E; Sklair-Levy M
Breast Cancer Res Treat; 2024 Jun; 205(2):281-285. PubMed ID: 38379091
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer screening in BRCA1/2 pathogenic sequence variant carriers during pregnancy and lactation.
Sorin V; Bufman H; Bernstein-Molho R; Faermann R; Friedman E; Raskin D; Balint Lahat N; Sklair-Levy M
Clin Imaging; 2024 Jul; 111():110189. PubMed ID: 38759599
[TBL] [Abstract][Full Text] [Related]
4. Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among
Faermann R; Friedman E; Kaidar-Person O; Weidenfeld J; Brodsky M; Shalmon A; Halshtok Neiman O; Gotlieb M; Yagil Y; Samoocha D; Madorsky Feldman D; Sklair-Levy M
Breast J; 2022; 2022():4317693. PubMed ID: 36349178
[TBL] [Abstract][Full Text] [Related]
5. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.
Krammer J; Pinker-Domenig K; Robson ME; Gönen M; Bernard-Davila B; Morris EA; Mangino DA; Jochelson MS
Breast Cancer Res Treat; 2017 Jun; 163(3):565-571. PubMed ID: 28343309
[TBL] [Abstract][Full Text] [Related]
7. Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography.
van Zelst JCM; Mus RDM; Woldringh G; Rutten MJCM; Bult P; Vreemann S; de Jong M; Karssemeijer N; Hoogerbrugge N; Mann RM
Radiology; 2017 Nov; 285(2):376-388. PubMed ID: 28609204
[TBL] [Abstract][Full Text] [Related]
8. Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.
Shimada S; Yoshida R; Nakashima E; Kitagawa D; Gomi N; Horii R; Takeuchi S; Ashihara Y; Kita M; Akiyama F; Ohno S; Saito M; Arai M
Breast Cancer; 2019 Nov; 26(6):846-851. PubMed ID: 30980249
[TBL] [Abstract][Full Text] [Related]
9. Abnormal Findings Detected by Multi-modality Breast Imaging and Biopsy Results in a High-risk Clinic.
Laitman Y; Feldman DM; Sklair-Levy M; Yosepovich A; Barshack-Nakar I; Brodsky M; Halshtok O; Shalmon A; Gotlieb M; Friedman E
Clin Breast Cancer; 2018 Aug; 18(4):e695-e698. PubMed ID: 29292184
[TBL] [Abstract][Full Text] [Related]
10. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers.
Ghunaim H; Laenen A; De Keyzer F; Soens J; Keupers M; Postema S; Neven P; Van Ongeval C
Eur J Radiol; 2022 Jan; 146():110074. PubMed ID: 34902667
[TBL] [Abstract][Full Text] [Related]
11. [GENOTYPE-PHENOTYPE CORRELATIONS BY SPECIFIC FOUNDER VARIANTS IN BRCA IN ISRAELI WOMEN].
Michaelson-Cohen R; Laitman Y; Kedar I; Baris-Feldman H; Reish O; Lieberman S; Bernstein-Molho R; Goldberg Y; Reznick Levi G; Gershoni R; Beller U; Levy-Lahad E; Catan R; Friedman E
Harefuah; 2023 Jun; 162(6):370-375. PubMed ID: 37394440
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy.
Fakkert IE; Jansen L; Meijer K; Kok T; Oosterwijk JC; Mourits MJ; de Bock GH
Breast Cancer Res Treat; 2011 Aug; 129(1):157-64. PubMed ID: 21373873
[TBL] [Abstract][Full Text] [Related]
13. Risk-reducing salpingo-oophorectomy and breast cancer incidence among Jewish BRCA1/BRCA2-mutation carriers-an Israeli matched-pair study.
Perri T; Levin G; Naor-Revel S; Eliassi-Revivo P; Lifshitz D; Friedman E; Korach J
Int J Gynaecol Obstet; 2022 May; 157(2):431-436. PubMed ID: 34324701
[TBL] [Abstract][Full Text] [Related]
14. An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers.
Madorsky-Feldman D; Sklair-Levy M; Perri T; Laitman Y; Paluch-Shimon S; Schmutzler R; Rhiem K; Lester J; Karlan BY; Singer CF; Van Maerken T; Claes K; Brunet J; Izquierdo A; Teulé A; Lee JW; Kim SW; Arun B; Jakubowska A; Lubinski J; Tucker K; Poplawski NK; Varesco L; Bonelli LA; Buys SS; Mitchell G; Tischkowitz M; Gerdes AM; Seynaeve C; Robson M; Kwong A; Tung N; Tessa N; Domchek SM; Godwin AK; Rantala J; Arver B; Friedman E
Breast Cancer Res Treat; 2016 Jun; 157(2):319-327. PubMed ID: 27117159
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced magnetic resonance imaging for risk-stratified screening in women with BRCA mutations or high familial risk for breast cancer: are we there yet?
Whitaker KD; Sheth D; Olopade OI
Breast Cancer Res Treat; 2020 Sep; 183(2):243-250. PubMed ID: 32621252
[TBL] [Abstract][Full Text] [Related]
16. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
17. Subsequent breast and high grade serous carcinomas after risk-reducing salpingo-oophorectomy in BRCA mutation carriers and patients with history of breast cancer.
Straub MM; Podoll MB; David SN; Wiesner GL; Desouki MM
Ann Diagn Pathol; 2018 Oct; 36():28-30. PubMed ID: 30055521
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer screening of pregnant and breastfeeding women with BRCA mutations.
Carmichael H; Matsen C; Freer P; Kohlmann W; Stein M; Buys SS; Colonna S
Breast Cancer Res Treat; 2017 Apr; 162(2):225-230. PubMed ID: 28138892
[TBL] [Abstract][Full Text] [Related]
19. Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers.
Fong A; Cass I; John C; Gillen J; Moore KM; Gangi A; Walsh C; Li AJ; Rimel BJ; Karlan BY; Amersi F
Am Surg; 2020 Oct; 86(10):1243-1247. PubMed ID: 33106023
[No Abstract] [Full Text] [Related]
20. Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers.
Grindedal EM; Heramb C; Karsrud I; Ariansen SL; Mæhle L; Undlien DE; Norum J; Schlichting E
BMC Cancer; 2017 Jun; 17(1):438. PubMed ID: 28637432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
